Phentermine: all 35 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and LymphomaNot yet recruitingNCT07790913Phase 2
• Phentermine's Impact on Treatment in TeensRecruitingNCT07282340Phase 2
• Individualized Pharmacological Approach to Obesity in Patients With Bipolar DisorderRecruitingNCT07213466Phase 4
• Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric SurgeryRecruitingNCT05975580Phase 4
• Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese PatientsRecruitingNCT04721873Phase 2
• A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese SubjectsCompletedNCT05215418Phase 4Results posted
• Phentermine/Topiramate for Uric Acid StonesCompletedNCT04621929Phase 2Results posted
• Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or ObesityCompletedNCT04614545Phase 4Results posted
• EMI-EHP Weight Management and Type 2 Diabetes Pragmatic TrialTerminatedNCT04531176Phase 4Results posted
• Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year OldsCompletedNCT04095104Phase 2Results posted
• Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral TreatmentCompletedNCT03779048Phase 4Results posted
• Lifestyle Modification and LiraglutideCompletedNCT02911818Phase 4Results posted
• A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese AdolescentsCompletedNCT02714062Phase 4Results posted
• Qsymia as an Adjunct to Surgical Therapy in the SuperobeseCompletedNCT02301416Phase 2Results posted
• Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese ParticipantsCompletedNCT02243202Phase 2Results posted
• A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese AdultsCompletedNCT01987427Phase 4Results posted
• Studying the Effects of Phentermine on Eating BehaviorCompletedNCT01886937Phase 4Results posted
• Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)CompletedNCT01616082Not applicableResults posted
• A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)CompletedNCT00796367Phase 3Results posted
• A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese AdultsCompletedNCT00745251Phase 1/2Results posted
• Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic AdultsTerminatedNCT00737633Phase 2Results posted
• A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic AdultsCompletedNCT00600067Phase 2Results posted
• A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in AdultsCompletedNCT00563368Phase 3Results posted
• Study of VI-0521 Compared to Placebo in Treatment of Obesity in AdultsCompletedNCT00554216Phase 3Results posted
• Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid ConditionsCompletedNCT00553787Phase 3Results posted
• Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese DiabeticsCompletedNCT00486291Phase 2Results posted
• Intermittent Phentermine for Obesity and Body CompositionCompletedNCT07870668Phase 4
• Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)Active, not recruitingNCT06854614Phase 4
• Long-term Effectiveness of the Antiobesity Medication PhentermineActive, not recruitingNCT05176626Phase 4
• Medications After Adolescent Bariatric SurgeryWithdrawnNCT04572217Phase 2
• Effectiveness and Tolerability of Phentermine in Patients Under Bariatric SurgeryCompletedNCT03849729Phase 4
• Phentermine/Gastric Band Weight Loss StudyWithdrawnNCT00771654Not applicable
• A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic ImpairmentCompletedNCT00768209Phase 1
• Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese AdultsCompletedNCT00518466Phase 1
• A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese SubjectsCompletedNCT00402077Phase 2

← Phentermine overview